Pep IQ
Part FiveSkin, Hair & HealingGHK-Cu
← Pep IQ
← Pep IQ

GHK-Cu

Also known as: Glycyl-L-Histidyl-L-Lysine Copper · GHK Copper Peptide · Gly-His-Lys
"A copper-binding tripeptide found in human plasma, saliva, and urine — and one of the most extensively studied peptides for wound healing and skin regeneration. Outperformed vitamin C and retinoic acid in a human collagen trial. Gets more interesting the deeper you look."
StructureGly-His-Lys (tripeptide) + Cu²⁺
Natural SourceHuman plasma, saliva, urine
Primary UsesSkin, wound healing, hair growth
Best EvidenceTopical skin / wound healing
Injectable statusFDA restricted compounding (2023)
Origin & Background

Discovered in Human Plasma — 50 Years of Research

GHK-Cu has one of the most legitimate origin stories in this book. It was first isolated from human plasma in 1973 by biochemist Loren Pickart — who noticed that aged plasma promoted liver cell survival in culture less effectively than young plasma, and traced the difference to this tiny tripeptide. Unlike most peptides in community use, GHK is genuinely endogenous — your body produces it and circulates it, and levels decline with age.

GHK (glycyl-L-histidyl-L-lysine) complexes naturally with copper (Cu²⁺) in the body — the copper complex is the biologically active form. Copper is an essential cofactor for lysyl oxidase and lysyl hydroxylase, the enzymes that cross-link collagen properly. Without adequate copper, newly synthesised collagen is weak. GHK-Cu brings the copper directly to sites that need it.

The peptide is found in the extracellular matrix — GHK sequences are present in the alpha-2(I) chain of type I collagen and can be released by proteases at wound sites. This means wound healing naturally liberates GHK, which then acts as a local repair signal. GHK-Cu has roughly 50 years of published research, has been studied in human clinical trials, and is widely used in cosmetic products — making it one of the best-documented compounds in this book.

Science & Mechanism

Gene Expression, Collagen Remodelling, and Copper Delivery

GHK-Cu's mechanism operates at multiple levels simultaneously. It is not simply a growth factor or a direct stimulant — it appears to function as a broad gene expression modulator, resetting cellular patterns toward more regenerative states.

Mechanism of Action

1
Collagen and elastin synthesis stimulation — activates fibroblasts to produce more Type I and Type III collagen and elastin. Human fibroblast studies show increases at concentrations as low as 0.01 nM. Also stimulates glycosaminoglycan synthesis and the small proteoglycan decorin, which organises collagen fibres.
2
MMP/TIMP balance modulation — simultaneously increases MMP-1 and MMP-2 (matrix metalloproteinases that break down damaged collagen) and TIMP-1 (tissue inhibitor that prevents excessive breakdown). This dual action remodels the extracellular matrix — removing old damaged collagen and building new — rather than just accumulating collagen.
3
Gene expression reset — Connectivity Map analysis found GHK significantly increased expression of 47 DNA repair genes and modulated 31 genes associated with the hallmarks of aging. Activates the proteasome system (cellular waste clearance). Researchers describe it as "resetting aging cells to more youthful patterns."
4
Angiogenesis and tissue recruitment — attracts immune and endothelial cells to injury sites, stimulates blood vessel and nerve outgrowth. GHK-Cu improved nerve regeneration when applied to severed nerve stubs in collagen tubes, increasing NGF, NT-3, NT-4, and axon count.
5
Anti-inflammatory and antioxidant — suppresses NFκB (a master inflammatory transcription factor), reduces TNF-β, and increases glutathione and ascorbic acid levels in wound tissue. COPD fibroblast restoration documented — suggesting lung tissue applications beyond skin.

The "copper uglies" caveat: Some users of topical copper peptide skincare report a phenomenon called "copper uglies" — an initial period that looks like accelerated skin aging rather than improvement. This is believed to occur because GHK-Cu upregulates MMP-1, which breaks down existing collagen before new collagen is built. If you increase breakdown faster than synthesis, you temporarily look worse before you look better. This effect is anecdotal and not well-studied, but it is consistent with the known MMP mechanism and worth knowing about before starting topical use.

Community Voices

The Skincare Peptide That Crossed Into Biohacking

GHK-Cu has an unusual community profile — it started in professional skincare formulations, was adopted by the cosmetics industry, and was subsequently picked up by the biohacking community as an injectable for systemic wound healing and anti-aging effects. The topical use has genuine clinical backing; the injectable use is largely community-driven and now FDA-restricted for compounding.

Community ReportAnecdotal — not clinical evidence
"GHK-Cu cream was the first peptide skincare I used that I could actually see working. After about six weeks, the texture improvement was noticeable to people who hadn't been told I was using anything. Not dramatic, but consistent and cumulative. The wrinkle trial data matches my experience."
Topical GHK-Cu has the most direct clinical trial support of any skincare peptide — a randomised double-blind trial showed 31.6% reduction in wrinkle volume versus Matrixyl 3000, and 55.8% reduction versus control serum. Community reports are consistent with this data and represent the most reliable signal for this compound.
Community ReportAnecdotal — not clinical evidence
"I tried SubQ GHK-Cu before the FDA compounding restrictions. The wound healing effect on a stubborn surgical scar was genuinely striking — faster than anything else I've used. Whether that's the same as the topical studies showing 40-50% wound closure acceleration, I can't say, but the direction was consistent."
Injectable GHK-Cu community use has declined significantly since 2023 FDA compounding restrictions. Most current community use is topical or oral (though oral bioavailability is uncertain). The wound healing data supports the mechanism even if the injectable form is now harder to access legitimately.
Benefits & Evidence

The Strongest Topical Evidence of Any Cosmetic Peptide

Skin Rejuvenation & Anti-Aging
Randomised double-blind trial: GHK-Cu in nano-lipid carrier (8 weeks, twice daily) produced 31.6% reduction in wrinkle volume versus Matrixyl 3000, 55.8% versus control. Earlier 1999 human trial: GHK-Cu increased collagen in 70% of volunteers, outperforming both vitamin C and retinoic acid. Multiple placebo-controlled trials confirm improved skin elasticity, firmness, and reduced photodamage in women around 50.
● Strong — multiple randomised human trials / topical application
🩹
Wound Healing
40-50% acceleration of wound closure in animal studies. Human data includes ischaemic open wound healing, diabetic ulcer improvement, and surgical incision outcomes. GHK is naturally released at wound sites from collagen degradation, making supplemental GHK a physiological amplification rather than a foreign signal.
● Strong animal / Moderate human wound data
💇
Hair Follicle Stimulation
GHK-Cu demonstrates protective effects against androgenetic alopecia, with follicle proliferation enhancement. Modulates growth factors relevant to hair cycle (GF stimulation, improved scalp circulation, anti-inflammatory effects on follicle environment). Weaker direct trial data than skin applications.
● Moderate — mechanistically supported, limited direct hair trials
🫁
COPD & Lung Tissue Repair
GHK-Cu restored replicative vitality to fibroblasts after radiation therapy. Specifically, COPD fibroblast function was restored in vitro. DNA repair gene upregulation (47 genes stimulated) is relevant to lung tissue integrity. An unexpected application from gene expression data analysis.
● Emerging — cell studies / no COPD clinical trials
Safety First

Excellent Topical Profile — Regulated Injectables

🛡️
GHK-Cu topically has an excellent long-term safety record. Decades of cosmetic use, multiple clinical trials, no serious adverse events documented. The injectable form is now restricted from commercial compounding by the FDA (2023), which limits legitimate access in the US but reflects regulatory caution rather than demonstrated harm.
Mild
Copper uglies (topical) — temporary apparent skin quality decline from MMP upregulation before collagen remodelling benefits appear. Anecdotal; not documented in trials. Usually resolves with continued use.
Mild
Skin irritation — occasional redness or sensitivity, particularly at higher concentrations. Generally well-tolerated across decades of cosmetic use.
Moderate
Copper overload risk (injectable/oral) — systemic copper supplementation at high doses can cause Wilson's disease-like effects. The concentrations in GHK-Cu at typical doses are unlikely to cause this, but anyone with copper metabolism disorders should exercise caution.
Unknown
MMP upregulation in oncological context — GHK-Cu increases MMP expression, which remodels the ECM. MMP upregulation in cancer contexts can theoretically influence tumour behaviour. Not documented as a risk in GHK studies, but theoretically worth flagging for people with active malignancies.

⚠ Critical Warnings

Injectable GHK-Cu is now restricted from commercial compounding in the US by FDA 2023 guidance. Grey-market injectable products are unverified for sterility and purity — do not use unverified injectable copper peptides.
Anyone with Wilson's disease or other copper metabolism disorders should not use GHK-Cu in any form without medical supervision.
Do not expect oral GHK-Cu to replicate topical effects — oral bioavailability of this small peptide has not been clearly established and gut degradation may limit systemic absorption.
This entry is for educational purposes only and does not constitute medical advice.
Synergy Stack

Nutrients, Supplements & Exercise

GHK-Cu is a copper-binding tripeptide that promotes collagen remodelling, wound healing, and skin regeneration. Its synergies are strongly skin and tissue-repair focused.

💊 Nutrients & Supplements
Vitamin C
500–1000mg/day
Strong evidence
The most important complement to GHK-Cu. Vitamin C is a rate-limiting co-factor for collagen synthesis — GHK-Cu stimulates fibroblasts to make collagen, but they need adequate vitamin C to actually do it.
Zinc
15–25mg/day
Moderate evidence
GHK-Cu already contains copper — zinc is its complement in collagen cross-linking enzyme systems. Maintain a zinc:copper ratio of roughly 8:1 to prevent copper-zinc imbalance with extended GHK-Cu use.
Retinoids (topical Vitamin A)
Topical retinol/retinaldehyde in evening routine
Strong evidence
The most evidence-backed skincare active. Retinoids and GHK-Cu work through complementary collagen-stimulating pathways. Retinoids enhance cell turnover; GHK-Cu drives matrix remodelling. Together they address skin ageing more completely than either alone.
Hyaluronic acid (topical)
Applied over GHK-Cu serum
Moderate evidence
Humectant that retains moisture in the dermis. GHK-Cu's collagen remodelling effects are enhanced in a well-hydrated skin environment.
Niacinamide
5% topical
Moderate evidence
Ceramide synthesis and barrier function. Complements GHK-Cu's matrix effects with skin barrier protection. Well-tolerated alongside copper peptides.
🏃 Exercise & Lifestyle
Facial massage or gua sha
Stimulates circulation and lymphatic drainage in skin. Enhances delivery of topically applied GHK-Cu into deeper skin layers.
Sun protection (SPF 30+)
UV damage destroys the collagen GHK-Cu is rebuilding. Sun protection is the single most important thing to maintain the gains from any collagen-supporting intervention.
Avoid copper-chelating compounds simultaneously
High-dose vitamin E and some antioxidants can chelate copper and reduce GHK-Cu's copper delivery. Keep them separate in your routine.
⏱ Timing & Protocol Notes
Apply GHK-Cu serum morning or evening. Vitamin C serum is best applied in the morning (photoprotective properties). Retinoids in the evening. Hyaluronic acid after active ingredients.

Disclaimer: These recommendations are educational and based on the known mechanisms of each compound. Individual responses vary. Consult a qualified healthcare provider before changing your supplement or exercise regimen, particularly when using experimental peptides.

Synergy Stack

Nutrients, Supplements & Exercise That Enhance This Peptide

The compounds and practices below have evidence supporting synergy with this peptide — either working on the same biological pathway, providing essential co-factors, or creating the physiological conditions that amplify the peptide's effects. Evidence ratings reflect the strength of the supporting science.

💊 Nutrients & Supplements
Vitamin C 500–1000mg daily
GHK-Cu stimulates collagen synthesis — vitamin C is the required cofactor for collagen cross-linking. Without it, new collagen is structurally weak.
● Strong evidence
Zinc 15–25mg daily
GHK-Cu contains copper — adequate zinc ensures the copper-zinc balance is maintained. Deficiency in either mineral impairs the metallopeptide's enzymatic functions.
● Strong evidence
Retinol (vitamin A) As directed, topical or low-dose oral
Works on collagen and skin remodelling via different mechanisms (RAR receptors vs GHK-Cu's fibroblast stimulation). The combination is synergistic for skin anti-ageing.
● Moderate evidence
Hyaluronic acid Topical or oral (120–240mg)
Supports the extracellular matrix that GHK-Cu is remodelling — hyaluronic acid provides hydration and structural support alongside collagen rebuilding.
● Moderate evidence
Silicon (horsetail extract or orthosilicic acid) 10–20mg daily
Essential for collagen cross-linking — a often-overlooked co-factor in connective tissue synthesis. Directly relevant to GHK-Cu's collagen remodelling.
● Moderate evidence
🏃 Exercise & Lifestyle
Resistance training 3–4x weekly
Mechanical loading stimulates fibroblast activity and collagen synthesis — the same cells GHK-Cu activates. Exercise and GHK-Cu signal from different angles to the same outcome.
● Strong evidence
Microneedling (topical use) Monthly professional treatment
Creates micro-channels that dramatically improve GHK-Cu penetration through the skin's stratum corneum barrier — the main limitation of topical application.
● Strong evidence
Avoid excessive sun exposure Use SPF daily
UV radiation generates the MMP activity GHK-Cu is trying to counterbalance. Sun protection preserves the remodelling work.
● Strong evidence
⚠ Avoid or limit: Wilson's disease is an absolute contraindication. Do not combine with excessive copper supplementation. Metallic applicators can disrupt the copper complex in GHK-Cu formulations.
The Honest Assessment

Where GHK-Cu Actually Stands

GHK-Cu has the most legitimate evidence base of any compound in the skin and wound healing space. It is endogenous, its natural function is tissue repair, its mechanism is comprehensively characterised, and it has multiple human clinical trials showing meaningful effects on collagen production and skin quality. The 1999 trial outperforming vitamin C and retinoic acid at collagen stimulation is a striking and well-cited finding.

The topical application is where the evidence is clearest — and that's also the safest and most accessible form. The injectable form, which attracted bodybuilders and biohackers seeking systemic wound healing effects, has been restricted from US compounding pharmacies. The gene expression data showing broader anti-aging and COPD effects is fascinating but lacks the clinical validation that the skin data has.

For skin and wound healing, GHK-Cu is one of the most credible peptides available at any level of evidence. The evidence is topical-specific, the safety record is excellent, and it is naturally something your body makes — just less of it as you age.

Editor's Summary
"GHK-Cu has the most solid human trial evidence of any cosmetic peptide — multiple RCTs outperforming vitamin C and retinoic acid at collagen stimulation, 50 years of research, and a genuinely endogenous mechanism. The topical evidence is real and accessible. The injectable form is now FDA-restricted. The gene expression data hints at much broader potential that hasn't been clinically validated yet. For skin: the best-evidenced option available."